Cresco Labs (CRLBF) Capital Expenditures Growth (1y) (2021 - 2026)
Cresco Labs (CRLBF) Capital Expenditures Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | 8.33% |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | -19.86% |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | -1.95% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 73.63% |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | -0.19% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | -37.60% |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | -42.11% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Cresco Labs | 295.09 Mn | 230.98 Mn | 86.95 Mn | 29.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.28% |
| Dec 31, 2025 | 265.12% |
| Sep 30, 2025 | -18.25% |
| Jun 30, 2025 | -18.81% |
| Mar 31, 2025 | -800.96% |
| Dec 31, 2024 | -84.16% |
| Sep 30, 2024 | 51.24% |
| Jun 30, 2024 | 72.23% |
| Mar 31, 2024 | -49.85% |
| Dec 31, 2023 | -30.71% |
| Sep 30, 2023 | 39.60% |
| Jun 30, 2023 | -190.48% |
| Mar 31, 2023 | 104.65% |
| Dec 31, 2022 | -10.27% |
| Sep 30, 2022 | 20.25% |
| Jun 30, 2022 | 53.24% |
| Mar 31, 2022 | -66.22% |
| Dec 31, 2021 | 7.74% |
| Mar 31, 2021 | 50.74% |